Adhera Therapeutics, Inc. (ATRX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 3, 2026, 9:30 AM EST
-0.00%
Market Cap 1.16K
Revenue (ttm) n/a
Net Income (ttm) -4.61M
Shares Out 11.63M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 6,285
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0100
Beta 726.30
RSI 46.34
Earnings Date n/a

About Adhera Therapeutics

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol ATRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.